InHandPlus was established in 2019. InHandPlus is developing an On-Device AI smartwatch and AI-based digital healthcare platform for personalized medication management. InHandPlus Medication Management Platform provides real-world data and evidence of medication adherence. InHand-Care platform improves medication adherence by more than 30%, and InHand-Watch analyzes medication behaviors with more than 99% accuracy. InHandPlus was selected for both global Merck and Bayer startup accelerating programs. InHandPlus actively collaborate with many international Pharmaceutical companies, CROs, hospitals, insurance companies, and telemedicine companies for successful clinical trials and better patient healthcare. InHandPlus won the CES Innovation Award in both 2022 & 2023. And InHand-Watch was designated as a government innovative procurement product.
InHand-Watch is a smartwatch with health management features such as medication administration and diet management. The On-Device AI technology lets users easily track their medication and dietary habits through the watch. Moreover, it can be connected to ChatGPT, which provides personalized health information. The InHand-Care App allows users and caregivers to monitor health records, while administrators can access this information through the InHand-Care Web. The smartwatch's monitoring system automatically collects medication adherence data without requiring additional user input and can detect fall detection. It can monitor medication, inhalers, glucometers, auto-injectors, and more. It can monitor medication, inhalers, glucometers, auto-injectors, and more.